Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Shirt Coola, a summer cooling spray for cloths; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Nightmin Nasal Respiration Tape; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eybon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; and Sawaday, a toilet air freshener. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through sales promotional campaigns, such as advertising and direct mail; and sells skincare products, health foods, and other items through e-commerce channels. Further, it engages in transportation, real estate management, and advertising planning and production businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Kobayashi Pharmaceutical Dividend Announcement
• Kobayashi Pharmaceutical announced a semi annually dividend of ¥59.00 per ordinary share which will be made payable on 2025-03-01. Ex dividend date: 2024-12-27
• Kobayashi Pharmaceutical annual dividend for 2024 was ¥102.00
• Kobayashi Pharmaceutical annual dividend for 2023 was ¥101.00
• Kobayashi Pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.67%
• Kobayashi Pharmaceutical's dividend growth over the last five years (2018-2023) was 8.88% year
• Kobayashi Pharmaceutical's dividend growth over the last ten years (2013-2023) was 1.62% year
Kobayashi Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-27 | ¥59.00 | semi annually | 2025-03-01 |
2024-06-27 | ¥43.00 | semi annually | 2024-09-05 |
2023-12-28 | ¥58.00 | semi annually | 2024-03-07 |
2023-06-29 | ¥43.00 | semi annually | 2023-09-07 |
2022-12-29 | ¥47.00 | semi annually | 2023-03-09 |
2022-06-29 | ¥38.00 | semi annually | 2022-09-08 |
2021-12-29 | ¥44.00 | semi annually | 2022-03-09 |
2021-06-29 | ¥37.00 | semi annually | 2021-09-09 |
2020-12-29 | ¥41.00 | semi annually | 2021-03-05 |
2020-06-29 | ¥34.00 | semi annually | 2020-09-10 |
2019-12-27 | ¥40.00 | semi annually | 2020-03-05 |
2019-06-26 | ¥33.00 | semi annually | 2019-09-05 |
2018-12-26 | ¥35.00 | semi annually | 2019-03-07 |
2018-06-27 | ¥31.00 | semi annually | 2018-09-06 |
2017-12-27 | ¥30.00 | semi annually | 2018-03-08 |
2017-06-28 | ¥28.00 | semi annually | 2017-09-07 |
2016-12-28 | ¥27.00 | semi annually | |
2016-09-28 | ¥25.00 | semi annually | |
2016-03-29 | ¥48.00 | semi annually | |
2015-09-28 | ¥48.00 | semi annually | |
2015-03-27 | ¥46.00 | semi annually | |
2014-09-26 | ¥44.00 | semi annually | |
2014-03-27 | ¥43.00 | semi annually | |
2013-09-26 | ¥43.00 | semi annually | |
2013-03-27 | ¥43.00 | semi annually |
Kobayashi Pharmaceutical Dividend per year
Kobayashi Pharmaceutical Dividend growth
Kobayashi Pharmaceutical Dividend Yield
Kobayashi Pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.67%. Interested in purchasing Kobayashi Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Kobayashi Pharmaceutical Financial Ratios
Kobayashi Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Kobayashi Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Kobayashi Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Kobayashi Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Kobayashi Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Kobayashi Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Kobayashi Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Kobayashi Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Kobayashi Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Kobayashi Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Kobayashi Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Kobayashi Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.